Soluble adhesion molecules in renal transplantation

Renal Failure

Volumn 18, Issue 1, 1996, Pages 75-83

  Bricio, Teresa ^a   Rivera, Mayte ^a   Molina, Ana ^a   Martin, Ana ^a   Burgos, Javier ^a   Mampaso, Francisco ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0029989265     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052776     Document Type: Article

References (21)

1. Mason DW, Moms PJ: Effector mechanisms in allograft rejection. Annu Rev Immunol 4:119-145, 1986.
2. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990.
3. Makgoba MW, Sanders ME, Shaw S: Functional evidence that intercellular adhesion molecules-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol 18:637-640, 1988.
4. Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated with antigen 1 (LFA-1). Cell 51:813-819, 1987.
5. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowski S, Hemmler ME, Lobb R: VCAM-1 on Activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577-584, 1990.
6. Rothlein P, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 147:3788-3793, 1991.
7. Seth R, Raymond FD, Makgoba MW: Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338:83-84, 1991.
8. Tsujisaki M, Imai K, Hirata Y et al: Detection of circulating intercellular adhesion molecule-1 antigen in malignant disease. Clin Exp Immunol 85:3-8, 1991.
9. Sasseville VG, Newman WA, Lackner AA, Smith MO, Lausen NCG, Beall D, Ringler DJ: Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol 141:1021-1030, 1992.
10. Mampaso F, Sanchez-Madrid F, Marcen R, Molina A, Pascual J, Bricio T, Martin A, Alvarez V: Expression of adhesion molecules in allograft renal dysfunction: a distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity. Transplantation 56:687-691, 1993.
11. Pascual J, Marcen R, Orofino F, et al: Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction. Transplantation 52:276-279, 1991.
12. Solez K, Axelsen RA, Benediktsson H et al: International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993.
13. Colvin RB: Cellular and molecular mechanisms of allograft rejection. Annu Rev Med 41:361, 1990.
14. Yoshimura N, Oka T, Kahan BD Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allografts recipients. Transplantation 51:172-176, 1991.
15. Imagawa DK, Millis JM, Seu P et al: The role of tumor necrosis factor in allograft rejection. Transplantation 51:57-62, 1991.
16. Cornaby A, Simpson MA, VannRice R et al: Interleukin-2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allografts recipients. Transplant Proc 20:827-1988.
17. Briscoe DM, Pober JS, Harmon HE, Cotran RS: Expression of vascular cell adhesion molecule-1 in human renal allografts. J Am Soc Nephrol 13:1180-1185, 1992.
18. Cosmi AB, Conti D, Delmonico F et al: In vivo effects of monoclonal antibody to ICAM-1 (CD 54) in nonhuman primates with renal allografts. J Immunol 144:4604-4612, 1990.
19. Stockenhuber F, Kramer G, Schenn G et al: Circulating ICAM-1: novel parameter of renal graft rejection. Transplant Proc 25:919-920, 1993.
20. Pigott R, Dillon LP, Hemingway Gearing AJH: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured cells. Biochem Biophys Res Commun 187:584-588, 1992.
21. Tadahiko K, Brewer MT, Baker SL et al: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331-8335, 1990.